Abstract
In 2002 Molesworth et al created a logistic regression model to investigate the spatial distribution of meningitis epidemics in Africa and determine geographical risk. We aim to understand if the meningitis belt geography and environmental risk factors have changed in the last 20 years by updating this analysis. Epidemic bacterial meningitis data from 2003-2022 were provided by WHO-AFRO. Districts (ADMN2) across Africa were coded as 1 if they had experienced a meningitis outbreak and 0 if they hadn’t. Environmental data were obtained from open sources. To preserve seasonal climate variation, monthly means of wind speed, rainfall, dust, and humidity were processed into climatic profiles using k-means clustering. Logistic regression was carried out with meningitis epidemic history as the dependent variable and k-means clusters of rainfall, dust, humidity, and windspeed, alongside average land-cover type as the independent variables. A sensitivity analysis was conducted excluding the Democratic Republic of Congo (DRC), due to limited laboratory confirmation of suspected cases. Rainfall, dust, and humidity demonstrated the strongest statistical association with meningitis outbreaks and were included in our final model. With a probability cutoff value of >0.4, our model had a specificity and sensitivity of 81.0% and 84.3% respectively in identifying districts having experienced a meningitis epidemic. With an extended dry season, the Sahelian region had the highest risk of meningitis outbreaks (probability >0.8). The inclusion/exclusion of the DRC had a significant impact on our model. Whilst Republic of the Congo, Gabon, Liberia, and Angola had a moderate risk of meningitis (probability >0.4) within our full model, no countries surrounding the meningitis belt were at risk for outbreaks within the sensitivity analysis. Although our research may suggest a south-westerly expansion of the meningitis belt this is difficult to verify. Surveillance of suspected meningitis cases should be accompanied by laboratory confirmation to improve outbreak definition.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was carried out as part of the Vaccine Impact Modelling Consortium (www.vaccineimpact.org), but the views expressed are those of the authors and not necessarily those of the Consortium or its funders. This work was supported by the Wellcome Trust via the Vaccine Impact Modelling Consortium [Grant Number 226727_Z_22_Z].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was not required for this research
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.